Patents-Review.com
🔗 Permalink
Assignee profile:

Aposense Ltd.

City:

Petach-Tikva

Country:

Israel

Published Applications:

17

Last publication date:

2025-07-31

Patent Grants:

15

Last grant date:

2025-06-24

Top Inventors for applications by Aposense Ltd.

These are the the leading inventors for applications assigned to Aposense Ltd.:

Recent patent applications by Aposense Ltd.

Aposense Ltd. based in Petach-Tikva, IL has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-07-31
US20250242036A1
Human necessities

TRANS-MEMBRANE DELIVERY SYSTEMS AND USES THEREOF

 #2 | 2021-02-25 ✅ Patent 12,337,036 granted on 2025-06-24
US20210052736A1
Human necessities

COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES

 #3 | 2020-12-17 ✅ Patent 11,230,710 granted on 2022-01-25
US20200392490A1
Chemistry; metallurgy

Compounds and methods for trans-membrane delivery of molecules

 #4 | 2019-01-10 ✅ Patent 10,195,286 granted on 2019-02-05
US20190008976A1
Human necessities

Compounds and methods for trans-membrane delivery of molecules

 #5 | 2018-08-30 ✅ Patent 11,318,206 granted on 2022-05-03
US20180243426A1
Human necessities

Compounds and methods for trans-membrane delivery of molecules

 #6 | 2018-07-26 ✅ Patent 11,286,246 granted on 2022-03-29
US20180208574A1
Chemistry; metallurgy

Pro-drugs and related methods

 #7 | 2017-04-13 ✅ Patent 9,993,563 granted on 2018-06-12
US20170100486A1
Human necessities

Compounds and methods for trans-membrane delivery of molecules

 #8 | 2016-05-12 ✅ Patent 9,889,202 granted on 2018-02-13
US20160129125A1
Human necessities

Compounds and methods for trans-membrane delivery of molecules

 #9 | 2016-04-21 ✅ Patent 9,687,556 granted on 2017-06-27
US20160106855A1
Human necessities

Compounds and methods for trans-membrane delivery of molecules

 #10 | 2015-03-12 ✅ Patent 9,192,680 granted on 2015-11-24
US20150072949A1
Human necessities

Pharmaceutical compounds

 #11 | 2015-03-05
US20150064111A1
Physics

NOVEL TARGETING AGENTS FOR DIAGNOSTIC AND THERAPEUTIC INDICATIONS

 #12 | 2013-12-05 ✅ Patent 8,916,537 granted on 2014-12-23
US20130324494A1
Chemistry; metallurgy

Pharmaceutical compounds

 #13 | 2011-12-01 ✅ Patent 8,530,444 granted on 2013-09-10
US20110294754A1
Chemistry; metallurgy

Pharmaceutical compounds

 #14 | 2008-11-13 ✅ Patent 7,947,253 granted on 2011-05-24
US20080279774A1
Human necessities

Perturbed membrane-binding compounds and methods of using the same

 #15 | 2008-01-17 ✅ Patent 7,670,590 granted on 2010-03-02
US20080014148A1
Chemistry; metallurgy

Perturbed membrane-binding compounds and methods of using the same

 #16 | 2007-10-04 ✅ Patent 8,101,666 granted on 2012-01-24
US20070232702A1
Chemistry; metallurgy

Methods and compounds for detection of medical disorders

 #17 | 2007-02-08 ✅ Patent 7,605,182 granted on 2009-10-20
US20070031326A1
Physics

Compounds that selectively bind to membranes of apoptotic cells

Also check out Aposense LTD.'s (Petach-Tikva, Israel) applicant profile with 11 patent applications submitted.

AssigneeID:

47881 ⎘